Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Frontiers in Clinical Diabetes and Healthcare|December 25, 2023
The benefits of GLP1 receptors in cardiovascular diseasesLamija Ferhatbegović, Denis Mršić, Amra Macić-DžankovićCurrent Atherosclerosis Reports|May 31, 2022
LDL-C: The Only Causal Risk Factor for ASCVD. Why Is It Still Overlooked and Underestimated?Lamija Ferhatbegović, Denis Mršić, Sabina Kušljugić, et al.Acta Clinica Croatica|February 4, 2026
NON-HDL-C MIGHT PREDICT MAJOR ADVERSE CARDIOVASCULAR EVENT OCCURRENCE IN STATIN-NAÏVE PATIENTS FOLLOWING FIRST-TIME MYOCARDIAL INFARCTION - A PRELIMINARY REPORTLamija Ferhatbegović, Farid Ljuca, Zumreta Kušljugić, et al.Medical Sciences (Basel, Switzerland)|April 24, 2026
Renal Biomarkers and Albuminuria Predict Early Adverse Outcomes in Cardiorenal Syndrome Type 2Minela Bećirović, Emir Bećirović, Emir Begagić, et al.Medicinski Glasnik : Official Publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina|February 11, 2024
Breaking habits: safety and efficacy of elective electrocardioversion of atrial fibrillation and atrial flutter in the setting of day hospitalAmmar Brkić, Minela Bećirović, Emir Bećirović, et al.Journal of Cardiovascular Pharmacology|April 21, 2026
Rivaroxaban safety and adherence in patients with nonvalvular atrial fibrillation: prospective, observational, cohort, postmarketing studyElnur Smajić, Elmir Jahić, Denis Mršić, et al.Pageof 1